HPV Vaccine Safety: Has the CDC abandoned its mission?
Posted Apr 06 2013 9:34am
By Norma Erickson
What would happen if a vaccine turned out to cause more health problems than the disease it was meant to protect against? Are medical consumers watching this scenario unfold with HPV vaccines?
The U.S. Center for Disease Control (CDC) states 90% of all HPV infections clear on their own with no symptoms or medical treatment. Yes, human papillomavirus (HPV) may be one of the most commonly sexually transmitted viruses in the country, but in the vast majority of cases there are no serious health consequences to being exposed to human papillomavirus.
In those cases where infections with the same genotype of HPV persist over time, abnormal cervical lesions may develop. These abnormal lesions (CIN), classified 1, 2, or 3, are typically called ‘precancerous’ lesions. Not many people are aware of the fact that most CIN1 lesions go away on their own within two years. 25-50% of CIN2 lesions regress on their own within the same two year time frame. According to the International Agency for Research on Cancer (IARC), World Health Organization, the results of a pooled analysis of studies published between 1950 and 1993 indicated only 12% of CIN3 lesions progress to invasive cervical cancer.
Chapter 2 of the IARC’s COLPOSCOPY AND TREATMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA: A BEGINNER’S MANUAL states:
“Despite women’s frequent exposure to HPV, development of cervical neoplasia is uncommon. Most cervical abnormalities caused by HPV infection are unlikely to progress to high-grade CIN or cervical cancer, as most of them regress by themselves. The long time frame between initial infection and overt disease indicates that several cofactors (e.g., genetic differences, hormonal effects, micronutrient deficiencies, smoking, or chronic inflammation) may be necessary for disease progression. Spontaneous regression of CIN may also indicate that many women may not be exposed to these cofactors.”
Please note this manual was designed to teach medical and nursing personnel in developing countries where diagnostic and therapeutic expertise is not readily available. In other words, the progression from HPV exposure to potential development of cervical cancer is similar in both developing countries and developed countries. It also indicates that several cofactors (risk factors) may be needed for HPV exposure to progress to abnormal lesions, much less cervical cancer.
What does this mean for the average medical consumer?
HPV has not been proven to cause cervical cancer without other risk factors being present.
Persistent infections with high-risk HPV genotypes may lead to the development of cervical cancer if other risk factors are present.
According to the IARC, risk factors that contribute to the development of cervical cancer precursors and cervical cancer include infection with certain oncogenic types of human papillomavirus (HPV), sexual intercourse at an early age, multiple sexual partners, multiparity (giving birth two/more times, or giving birth to twins), long-term oral contraceptive use, tobacco smoking, low socioeconomic status, infection with Chlamydia trachomatis, micronutrient deficiency and a diet deficient in vegetables and fruits.
These are all facts that CDC officials know, or should know. Given this, how can these same CDC officials recommend and promote the universal use of HPV vaccines in an attempt to eliminate one risk factor involved in the development of cervical cancer?
Of equal concern is that the CDC knows the cervical cancer death rate in the United States has decreased substantially due largely to the introduction and wide use of pap smears.
Slight pelvic discomfort or pain during the procedure
Temporary abdominal cramping during or shortly after the procedure
Mild vaginal bleeding for up to 24 hours following the procedure
CDC officials also know that pap smears can identify abnormal cervical lesions long before they progress to cervical cancer. The CDC knows pap smears already provide a safe, affordable, necessary and effective means of preventing cervical cancer and cervical cancer deaths.
Despite all of this knowledge, the CDC wholeheartedly recommends two HPV vaccines, Gardasil and Cervarix, claiming both protect against cervical cancer in women.
However, because pre-licensure clinical trials often do not detect rare adverse events or adverse events related to special populations, the CDC and FDA are both responsible for ongoing safety monitoring of HPV and other vaccines.
Vaccines continue to be monitored for safety after they are licensed. This is because pre-licensure trials are often too small to detect rare events and special populations may not be adequately represented. Since licensure, CDC and FDA have been closely checking the safety of HPV vaccines through 3 monitoring systems. These systems can monitor adverse events (health problems) already known to be caused by vaccines, as well as detect rare adverse events that were not identified during pre-licensure clinical trials. The 3 systems are:
“These vaccine safety studies continue to show that HPV vaccines are safe.”
A simple analysis of the VAERS database alone does not support the CDC’s claims. The chart below illustrates adverse events reported after Gardasil and Cervarix compared against reports after the 13 other vaccines recommended for ages 7-18, for the period of time HPV vaccines have been on the market. Why do HPV vaccines appear to be vastly over represented in the adverse events database?
Does this not indicate some sort of safety signal?
HPV Vaccines: No Safety Signal?
We discussed above the three side effects reported after pap smears, none of which are life threatening. Compare them to the following list of new medical conditions reported to VAERS after HPV vaccines:
Abortion/Stillbirth/Miscarriage, Addison’s Disease, Adrenal failure/problems, Allergies, Anxiety/Panic attacks, Appetite loss, Arthritis, Asthma attacks, Autistic–like symptoms, Autoimmune Disease (Lupus/Mixed Connective Tissue Disease), Back pain, Bacterial Vaginosis, Bladder issues, Bleeding gums, Blindness, Bloating, Blood Sugar Issues, Bloody stools, Brain fog, Brain Inflammation, Brain lesions, Bronchitis, Cervical cancer, Chemical sensitivity, Chest pains, Convulsions, Chronic Fatigue Syndrome, Constipation, Cytomegalovirus (CMV), Death, Degenerative disk disease, Dehydration, Depression, Diabetes, Diarrhea, Dizziness, Dyslexia, Dysplasia, Early Onset of Menopause, Enlarged fallopian tubes, Enlarged liver, Epstein Barr Virus (EBV), Extreme pain in the tailbone area, Fainting, Fatigue, Fertility problems, Fever, Fever blisters, Fibromyalgia, Food allergies, Gallbladder issues, Genital Warts, Gray film on teeth, Guillain-Barre Syndrome, Hair growth in strange places, Hair loss, Hallucinations, Hand/Leg Weakness, Hashimoto’s Disease, Head pressure, Headache, Hearing loss (Temporary/Permanent), Hearing sensitivity, Heart Palpitations, Heart arrhythmia, High levels of metals in blood: aluminium, mercury, Hot/Cold Intolerance, HPV, Infertility, Insomnia, Itching, IUD discomfort, Joint pain, Kidney Failure, Kidney issues, Knee pain, Leaky Gut Syndrome, Light sensitivity, Lip spots, Liver Failure, Loss of bladder control, Lupus, Memory Loss (short-term/long-term), Menstrual cycle changes, Metallic taste in mouth, Migraines, Miscarriage, Mood Swings, Moles, Mononucleosis, Multiple Sclerosis (MS), MS-like symptoms, Muscle aches, Muscle spasms, Muscle tension, Nausea, Neurological reactions to fungal metabolites, Neurological symptoms , Night sweats, Non-Hodgkin’s Lymphoma, Numbness, Other types of cancer, Ovarian failure, Paleness, Paralysis, Pancreatitis, PCOS (Poly-Cystic Ovarian Syndrome), Pelvic Inflammatory Disease (PID), Pelvic pain, Personality changes, Pins/Needles in Extremities, Pleural effusion, Pneumonia, Postural Orthostatic Tachycardia Syndrome (Orthostatic Intolerance), Random twitching of extremities Rash, Reynaud’s Phenomenon (loss of blood circulation to hands and/or feet), Regression, Rheumatoid arthritis, Ruptured ovarian cysts, Seizures, Sensitivity to commercially processed citric acid, MSG, sulfur and other additives, Severe nerve pain syndrome, Shortness of breath, Sleep Apnea, Slurred speech, Smell sensitivity, Sore throat, Sound sensitivity w/Anxiety, Stomach ache, Stomach pain, Sudden drops in blood pressure, Swelling/Edema, Swollen lymph nodes, Thyroid Issues, Thrombosis Toothaches/Teeth Changes, Tremors: hand and/or leg, Uterine spasms, Urinary Tract Infection (UTI), Vision loss (Temporary/permanent), Vision Problems – abnormal pupillary function/dilation, Vomiting blood, Weight gain or loss (20 – 30 lbs)
Keep in mind, a report to the VAERS system does not mean the symptoms were caused by the vaccine administered before the new medical condition appeared. A report to the VAERS does not mean the new medical condition is NOT causally associated with the vaccine either. VAERS is simply an ‘early warning’ system. It is up to the CDC and FDA to examine the reports to determine whether or not a safety signal exists.
Any reasonable person looking at the data would struggle to understand how the CDC can recommend the addition of HPV vaccines to the cervical cancer prevention protocol when there is such disparity between potential adverse events?
Any reasonable person would wonder how the CDC can recommend HPV vaccines as a good strategy for cancer prevention when pap smears have already reduced the cervical cancer rates so significantly without all of these potential risks, not to mention at a much lower cost to individuals and society?
“For over 60 years, CDC has been dedicated to protecting health and promoting quality of life through the prevention and control of disease, injury, and disability. We are committed to programs that reduce the health and economic consequences of the leading causes of death and disability, thereby ensuring a long, productive, healthy life for all people.”
Accountability — as diligent stewards of public trust and public funds, we act decisively and compassionately in service to the people’s health. We ensure that our research and our services are based on sound science and meet real public needs to achieve our public health goals.
Respect — we respect and understand our interdependence with all people, both inside the agency and throughout the world, treating them and their contributions with dignity and valuing individual and cultural diversity. We are committed to achieving a diverse workforce at all levels of the organization.
Integrity — we are honest and ethical in all we do. We will do what we say. We prize scientific integrity and professional excellence.
Is the CDC living up to its mission statement?
CDC officials know continued pap screening is recommended by both HPV vaccine manufacturers, despite vaccination status because there are high-risk HPV genotypes not targeted by either Gardasil or Cervarix.
The CDC knows there are no reported deaths or permanent injuries reported after pap smears.
The CDC officials know or should know all of the facts outlined above.
Medical consumers need to ask themselves:
Has the CDC abandoned its mission in an effort to promote potentially dangerous vaccines of questionable benefit?